Transcatheter Tricuspid Valve Implantation by Femoral Approach in Trivalvular Heart Disease

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy. Electronic address: .
The American journal of cardiology (Impact Factor: 3.28). 08/2013; 112(7). DOI: 10.1016/j.amjcard.2013.05.043
Source: PubMed


A man with severe rheumatic trivalvular disease was treated with surgical implantation of mechanical aortic and mitral prostheses at the age of 30 years and tricuspid bioprosthesis at the age of 50 years. At 61 years of age, he developed severe symptomatic tricuspid regurgitation due to bioprosthesis degeneration and was judged at very high risk for a third surgical approach. The investigators describe the successful transfemoral positioning of a 29-mm Edwards SAPIEN XT percutaneous valve inside the degenerated tricuspid prosthesis, with excellent acute results and no major complications. In conclusion, percutaneous valve-in-valve treatment of degenerated bioprostheses is feasible by the transfemoral route and may be of assistance in very selected patients at high surgical risk.

1 Follower
26 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim: The aim of this study was to evaluate the association of baseline tricuspid regurgitation (TR) on the outcomes after percutaneous mitral valve repair (PMVR) with the MitraClip system. Methods and results: Data from 146 consecutive patients with functional mitral regurgitation (MR) were obtained. Two different groups, dichotomized according to the degree of pre-procedural TR (moderate/severe, n = 47 and none/mild, n = 99), had their clinical and echocardiographic outcomes through 12-month compared. At 30-day, the primary safety endpoint was significantly higher in moderate/severe TR compared with none/mild TR (10.6 vs. 2.0%, P = 0.035). Marked reduction in MR grades observed post-procedure were maintained through 12 months. Although NYHA functional class significantly improved in both groups compared with baseline, it was impaired in moderate/severe TR compared with the none/mild TR group (NYHA > II at 30 day: 33.3 vs. 9.2%, P < 0.001; at 1 year: 38.5 vs. 12.3%, respectively, P = 0.006). Left ventricle reverse remodelling and ejection fraction improvement were revealed in both groups. The primary efficacy endpoint at 12-month determined by freedom from death, surgery for mitral valve dysfunction, or grade ≥ 3+ MR was comparable between groups, but combined death and re-hospitalization for heart failure rates were higher in the moderate/severe TR group. Multivariable Cox regression analysis demonstrated that baseline moderate/severe TR and chronic kidney disease were independent predictors of this combined endpoint. Conclusions: Although PMVR with MitraClip led to improvement in MR, TR, and NYHA functional class in patients with baseline moderate/severe TR, the primary safety endpoint at 30-day was impaired, while moderate/severe TR independently predicted death and re-hospitalization for heart failure at 12-month.
    European Heart Journal – Cardiovascular Imaging 06/2014; 15(11). DOI:10.1093/ehjci/jeu114 · 2.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Contexte Le remplacement valvulaire percutanée avec la technique « valve-in-valve » (VIV) dans une bioprothèse défaillante est une technique innovante en cardiologie. Objectif Le but de cette étude est de rapporter une expérience française dans le remplacement tricuspide VIV et une revue de la littérature. Méthodes Nous avons approché différents centres et collecté 10 cas non publiés. Une revue de la littérature a pu identifier 71 patients incluant nos 10 patients. Resultats Cas non publiés : les raisons du remplacement étaient une sténose tricuspide significative (n = 4), une fuite tricuspide significative (n = 1) et une lésion mixte (n = 5). La mise en place a été effectuée à un âge moyen de 28 ± 17 ans. Une valve Melody de 22 mm a été implantée chez 7 patients, une valve SAPIEN d’Edwards chez 3 patients. L’implantation a réussi chez tous les patients malgré 2 embolisations dans les cavités droites : la valve a été stabilisée contre l’anneau tricuspide avec un stent auto-expansif avant l’implantation d’une seconde valve SAPIEN d’Edwards. Chez tous les patients sauf un, la classe fonctionnelle s’est améliorée. Le gradient tricuspide est passé de 9 ± 2,45 mmHg à 3,65 ± 0,7 mmHg (p = 0,007), et les patients n’avaient plus de fuite tricuspide ou une minuscule. La revue de la littérature : une valve Melody a été implantée chez 41 patients, une valve Edwards SAPIEN chez 29 patients, et une valve Braile chez un patient. Les résultats immédiats sont comparables à ceux de cette série mais les résultats à moyen terme ne sont pas encore disponibles. Les aspects cliniques et hémodynamiques sont discutés. Conclusion Le remplacement tricuspide par une technique VIV utilisant la valve Melody ou la valve SAPIEN d’Edwards est réalisable et efficace chez des patients sélectionnés avec une bioprothèse défaillante.
    Archives of Cardiovascular Diseases 10/2014; 107(11). DOI:10.1016/j.acvd.2014.07.051 · 1.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Minimally invasive transcatheter technologies have demonstrated substantial promise for the diagnosis and the treatment of cardiovascular diseases. For example, transcatheter aortic valve implantation is an alternative to aortic valve replacement for the treatment of severe aortic stenosis, and transcatheter atrial fibrillation ablation is widely used for the treatment and the cure of atrial fibrillation. In addition, catheter-based intravascular ultrasound and optical coherence tomography imaging of coronary arteries provides important information about the coronary lumen, wall, and plaque characteristics. Qualitative and quantitative analysis of these cross-sectional image data will be beneficial to the evaluation and the treatment of coronary artery diseases such as atherosclerosis. In all the phases (preoperative, intraoperative, and postoperative) during the transcatheter intervention procedure, computer vision techniques (e.g., image segmentation and motion tracking) have been largely applied in the field to accomplish tasks like annulus measurement, valve selection, catheter placement control, and vessel centerline extraction. This provides beneficial guidance for the clinicians in surgical planning, disease diagnosis, and treatment assessment. In this paper, we present a systematical review on these state-of-the-art methods. We aim to give a comprehensive overview for researchers in the area of computer vision on the subject of transcatheter intervention. Research in medical computing is multi-disciplinary due to its nature, and hence, it is important to understand the application domain, clinical background, and imaging modality, so that methods and quantitative measurements derived from analyzing the imaging data are appropriate and meaningful. We thus provide an overview on the background information of the transcatheter intervention procedures, as well as a review of the computer vision techniques and methodologies applied in this area.
    IEEE Journal of Translational Engineering in Health and Medicine 06/2015; 3:1-31. DOI:10.1109/JTEHM.2015.2446988

Similar Publications